Form 4: AbbVie Director Thomas C. Freyman Reports Stock Transactions

AbbVie Inc. director Thomas C. Freyman reported transactions involving restricted stock units and common stock.

Summary

• Thomas C. Freyman, a director at AbbVie Inc., has filed a Form 4 detailing changes in his beneficial ownership of company securities.
• The transactions include the acquisition of 1,118 restricted stock units (RSUs) awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program.
• These RSUs are payable in AbbVie common stock on a one-to-one basis upon separation from service, death, or a change in control.
• Additionally, the filing indicates indirect beneficial ownership of 4,000 shares held by Freyman's spouse in a revocable trust, of which Freyman disclaims ownership.
• Further indirect beneficial ownership is reported for 1,941 shares held in an irrevocable trust for the benefit of Freyman's son, with his spouse as trustee, where Freyman also disclaims beneficial ownership.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports routine stock unit awards and indirect holdings with disclaimed beneficial ownership, rather than significant new purchases or sales by the director.

Positives

• Director Freyman continues to hold a significant beneficial interest in AbbVie, with a total of 127,869 shares reported after the transactions.
• The acquisition of RSUs indicates continued incentive alignment between management and shareholders.
• The filing demonstrates transparency in reporting beneficial ownership changes.

Negatives

• The filing does not disclose the value or price at which the RSUs were awarded, making it difficult to assess the financial impact of this award.
• Freyman disclaims beneficial ownership of shares held in trusts managed by his spouse, which could be interpreted as a reduced direct stake in those specific holdings.

Risks

• The RSUs are subject to vesting conditions tied to separation from service, death, or change in control, meaning their ultimate realization depends on future events.
• The disclaimer of beneficial ownership for shares held in trusts managed by his spouse could be a point of scrutiny regarding ultimate control and benefit.

Future Outlook

The restricted stock units awarded will be paid out on a one-to-one basis in shares of AbbVie common stock on the earlier of the director's separation from service, death, or the occurrence of a change in control.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions in the pharmaceutical and biotechnology sectors, providing transparency on executive and director holdings.

Related Party Transactions

• Indirect beneficial ownership of securities held in trusts where the reporting person's spouse is the trustee and/or the trust is revocable by the spouse.

Stakeholder Impact

• Shareholders gain insight into director compensation and ownership structure.
• The reporting person's continued involvement and equity awards signal ongoing commitment.

Next Steps

• Restricted stock units will be paid out upon the occurrence of specific events (separation from service, death, or change in control).

Key Dates

Keywords

AbbVie Inc., ABBV, Form 4, SEC Filing, Beneficial Ownership, Director Transactions, Restricted Stock Units, Common Stock, Insider Trading, Thomas C. Freyman